login
  Password reminder
Cardiac Rhythm News
Contact the editor Visit Cardiac Rhythm News Twitter feed Visit Cardiac Rhythm News Facebook page
 

One in 1,000 risk of death from catheter ablation for AF


Tuesday, 05 May 2009 14:23

One in every 1,000 catheter ablations of atrial fibrillation results in the death of the patient, according to a study published in the 12 May 2009 issue of the Journal of the American College of Cardiology.


The authors of the article "Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial Fibrillation" wrote that "knowledge of possible precipitating causes is key to operators and needs to be considered during decision making with patients."


The purpose of the study, led by Dr Ricardo Cappato, Arrhythmia and Electrophysiology Center, Policlinico San Donato, Milan, Italy, was to provide a systematic multicentre survey on the incidence and causes of death occurring in the setting of or as a consequence of catheter ablation of atrial fibrillation.


Using a retrospective case series, data relevant to the incidence and cause of intra- and post-procedural death occurring in patients undergoing ablation of atrial fibrillation between 1995 and 2006 were collected from 162 of 546 identified centres worldwide.


Thirty-two deaths (.98 per 1,000 patients) were reported during 45,115 procedures in 32,569 patients. Causes of deaths included tamponade in eight patients (one later than 30 days), stroke in five patients (two later than 30 days), atrioesophageal fistula in five patients, and massive pneumonia in two patients. Myocardial infarction, intractable torsades de pointes, septicemia, sudden respiratory arrest, extrapericardial pulmonary vein perforation, occlusion of both lateral pulmonary veins, hemothorax, and anaphylaxis were reported to be responsible for one death each, while asphyxia from tracheal compression secondary to subclavian hematoma, intracranial bleeding, acute respiratory distress syndrome, and esophageal perforation from an intraoperative transesophageal echocardiographic probe were causes of one late death each.




Add New Comment

Most popular


Thursday, 26 Feb 2015
Vitaria delivers autonomic regulation therapy for patients who have moderate to severe heart failure with left ventricular dysfunction (ejection fraction < 40%), and who remain symptomatic despite ... Vitaria vagal nerve stimulation system receives CE mark for treatment of chronic heart failure

Sorin announces enrolment of first patients in the Vanguard clinical study
Thursday, 12 Feb 2015
The Vanguard (Vagal nerve stimulation safeguarding heart failure patients) clinical study evaluates Equilia, a neurostimulation system for heart failure patients. Sorin announces enrolment of first patients in the Vanguard clinical study

Boston Scientific receives FDA approval for Watchman left atrial appendage closure device
Monday, 16 Mar 2015
The device offers an alternative to long-term warfarin therapy for stroke risk reduction in patients with non-valvular atrial fibrillation. Boston Scientific receives FDA approval for Watchman left atrial appendage closure device

Features


SERVE-HF could be a wake-up call for cardiologists about central sleep apnoea
Tuesday, 24 Mar 2015
Martin Cowie (Imperial College London, London, UK) is the principal investigator of the SERVE-HF study, which is assessing the use of adaptive servo-ventilation (PaceWave, ResMed) in chronic heart ... SERVE-HF could be a wake-up call for cardiologists about central sleep apnoea

A new study explores heart failure treatment with vagal nerve stimulation
Thursday, 12 Mar 2015
Albert Hagège (Georges Pompidou European Hospital in Paris, France), principal investigator of Vanguard, a new study exploring the safety and efficacy of vagal nerve stimulation in heart failure ... A new study explores heart failure treatment with vagal nerve stimulation

Profiles


Hung-Fat Tse
Tuesday, 03 Feb 2015
While Hung-Fat Tse’s initial research interests focused on device therapy for cardiac arrhythmias, ... Hung-Fat Tse

Massimo Santini
Friday, 10 Oct 2014
Massimo Santini performed the first fulguration of the atrioventricular node of resistant ... Massimo Santini

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions